Blocking IL-6 could not only slow tumor progression but also reactivate NK cells suppressed by peri-pancreatic adipose tissue or tumor-infiltrating cells, offering a promising therapeutic approach for the treatment of pancreatic tumors. This evidence concerns the gene IL6 and pancreatic neoplasm.